Clinical Trials

NCT03199885 | TERMINATED | PHASE3
190 participants

Testing the Drug Atezolizumab or Placebo With Usual Therapy in First-Line HER2-Positive Metastatic Breast Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-29
Start Date:
2019-04-05
Completion:
2024-04-30
Conditions
  • Metastatic Breast Adenocarcinoma
  • Metastatic HER2-Positive Breast Carcinoma
  • Recurrent Breast Adenocarcinoma
  • Recurrent HER2-Positive Breast Carcinoma
  • Stage III Breast Cancer AJCC v7
  • Stage IV Breast Cancer AJCC v6 and v7
  • Unresectable Breast Carcinoma
  • Unresectable HER2-Positive Breast Carcinoma
Interventions
  • DRUG
  • PROCEDURE
  • BIOLOGICAL
  • OTHER
NCT03157323 | ACTIVE_NOT_RECRUITING | NA
88 participants

Low GI Diet in Children and Adolescents With ALL

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-29
Start Date:
2017-06-01
Completion:
2023-06-01
Conditions
  • Acute Lymphoblastic Leukemia, Pediatric
  • Obesity, Pediatric
Interventions
  • BEHAVIORAL
No Results Yet
NCT02984124 | COMPLETED | PHASE2/PHASE3
182 participants

Communication During Hospitalization About Resuscitation Trial

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-29
Start Date:
2016-12-31
Completion:
2023-03-31
Conditions
  • Severe Life-limiting COPD
  • Severe Life-limiting Heart Failure
  • Severe Life-limiting Cirrhosis
  • Severe Life-limiting Malignancy
  • Severe Functional Impairment
  • End Stage Renal Disease
Interventions
  • BEHAVIORAL
No Results Yet
NCT02954874 | ACTIVE_NOT_RECRUITING | PHASE3
1155 participants

Testing MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-29
Start Date:
2017-01-18
Completion:
2027-05-31
Conditions
  • Breast Carcinoma In Situ
  • Invasive Breast Carcinoma
  • Stage I Breast Cancer AJCC v7
  • Stage II Breast Cancer AJCC v6 and v7
  • Stage III Breast Cancer AJCC v7
  • Triple-Negative Breast Carcinoma
Interventions
  • PROCEDURE
  • OTHER
  • BIOLOGICAL
  • RADIATION
No Results Yet
NCT02879695 | ACTIVE_NOT_RECRUITING | PHASE1
28 participants

Blinatumomab and Nivolumab With or Without Ipilimumab in Treating Patients With Poor-Risk Relapsed or Refractory CD19+ Precursor B-Lymphoblastic Leukemia

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-29
Start Date:
2017-10-25
Completion:
2023-05-22
Conditions
  • Recurrent B Acute Lymphoblastic Leukemia
  • Recurrent Mixed Phenotype Acute Leukemia
  • Refractory B Acute Lymphoblastic Leukemia
  • Refractory Mixed Phenotype Acute Leukemia
Interventions
  • PROCEDURE
  • BIOLOGICAL
NCT02834013 | ACTIVE_NOT_RECRUITING | PHASE2
818 participants

Nivolumab and Ipilimumab in Treating Patients With Rare Tumors

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-29
Start Date:
2017-01-30
Completion:
2027-05-01
Conditions
  • Acinar Cell Carcinoma
  • Adenoid Cystic Carcinoma
  • Adrenal Cortical Carcinoma
  • Adrenal Gland Pheochromocytoma
  • Anal Canal Neuroendocrine Carcinoma
  • Anal Canal Undifferentiated Carcinoma
  • Angiosarcoma
  • Apocrine Neoplasm
  • Appendix Mucinous Adenocarcinoma
  • Bartholin Gland Transitional Cell Carcinoma
  • Basal Cell Carcinoma
  • Bladder Adenocarcinoma
  • Breast Metaplastic Carcinoma
  • Cervical Adenocarcinoma
  • Cholangiocarcinoma
  • Chordoma
  • Colorectal Squamous Cell Carcinoma
  • Desmoid Fibromatosis
  • Endometrial Transitional Cell Carcinoma
  • Endometrioid Adenocarcinoma
  • Esophageal Neuroendocrine Carcinoma
  • Esophageal Undifferentiated Carcinoma
  • Extrahepatic Bile Duct Carcinoma
  • Extramammary Paget Disease
  • Fallopian Tube Adenocarcinoma
  • Fallopian Tube Transitional Cell Carcinoma
  • Fibromyxoid Tumor
  • Gallbladder Carcinoma
  • Gastric Neuroendocrine Carcinoma
  • Gastric Squamous Cell Carcinoma
  • Gastric Undifferentiated Carcinoma
  • Gastrointestinal Stromal Tumor
  • Gestational Trophoblastic Tumor
  • Giant Cell Carcinoma
  • Human Papillomavirus-Independent Cervical Adenocarcinoma, Clear Cell-Type
  • Intestinal Neuroendocrine Carcinoma
  • Intrahepatic Cholangiocarcinoma
  • Lung Neuroendocrine Tumor
  • Lung Sarcomatoid Carcinoma
  • Major Salivary Gland Carcinoma
  • Malignant Neoplasm of Unknown Primary
  • Malignant Odontogenic Neoplasm
  • Malignant Peripheral Nerve Sheath Tumor
  • Malignant Solid Neoplasm
  • Malignant Testicular Sex Cord-Stromal Tumor
  • Metastatic Pituitary Neuroendocrine Tumor
  • Minimally Invasive Lung Adenocarcinoma
  • Mixed Mesodermal (Mullerian) Tumor
  • Mucinous Adenocarcinoma
  • Mucinous Cystadenocarcinoma
  • Nasal Cavity Adenocarcinoma
  • Nasal Cavity Carcinoma
  • Nasopharyngeal Carcinoma
  • Nasopharyngeal Low Grade Papillary Adenocarcinoma
  • Nasopharyngeal Undifferentiated Carcinoma
  • Oral Cavity Carcinoma
  • Oropharyngeal Undifferentiated Carcinoma
  • Ovarian Adenocarcinoma
  • Ovarian Germ Cell Tumor
  • Ovarian Mucinous Adenocarcinoma
  • Ovarian Squamous Cell Carcinoma
  • Ovarian Transitional Cell Carcinoma
  • Pancreatic Acinar Cell Carcinoma
  • Pancreatic Neuroendocrine Carcinoma
  • Paraganglioma
  • Paranasal Sinus Adenocarcinoma
  • Paranasal Sinus Carcinoma
  • Parathyroid Gland Carcinoma
  • PEComa
  • Penile Squamous Cell Carcinoma
  • Peritoneal Mesothelial Neoplasm
  • Placental Choriocarcinoma
  • Primary Peritoneal High Grade Serous Adenocarcinoma
  • Pseudomyxoma Peritonei
  • Rare Disorder
  • Scrotal Squamous Cell Carcinoma
  • Seminal Vesicle Adenocarcinoma
  • Seminoma
  • Serous Cystadenocarcinoma
  • Small Intestinal Adenocarcinoma
  • Small Intestinal Squamous Cell Carcinoma
  • Spindle Cell Neoplasm
  • Teratoma With Somatic-Type Malignancy
  • Testicular Non-Seminomatous Germ Cell Tumor
  • Thyroid Gland Carcinoma
  • Tracheal Carcinoma
  • Transitional Cell Carcinoma
  • Ureter Adenocarcinoma
  • Ureter Squamous Cell Carcinoma
  • Urethral Adenocarcinoma
  • Urethral Squamous Cell Carcinoma
  • Vaginal Adenocarcinoma
  • Vaginal Squamous Cell Carcinoma, Not Otherwise Specified
  • Vulvar Carcinoma
Interventions
  • PROCEDURE
  • BIOLOGICAL
No Results Yet
NCT02757859 | ACTIVE_NOT_RECRUITING | NA
845 participants

WASH Trial: Intraoperative Lavage as a Treatment for Pancreatic Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-29
Start Date:
2016-04-27
Completion:
2028-08-31
Conditions
  • Acinar Cell Carcinoma
  • Ampulla of Vater Adenocarcinoma
  • Cholangiocarcinoma
  • Duodenal Adenocarcinoma
  • Pancreatic Adenocarcinoma
  • Pancreatic Ductal Adenocarcinoma
  • Pancreatic Intraductal Papillary Mucinous Neoplasm
  • Periampullary Adenocarcinoma
Interventions
  • PROCEDURE
  • OTHER
No Results Yet
NCT02710916 | COMPLETED | NA
109 participants

SD-OCT Multimodal Analysis in GLaucoma

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-29
Start Date:
2016-02-22
Completion:
2018-12-21
Conditions
  • Glaucoma
  • Ocular Hypertension
  • Eye Diseases
Interventions
  • DEVICE
No Results Yet
NCT02639325 | RECRUITING
100 participants

Tumor Related Epilepsy

Study Type:
OBSERVATIONAL
Last Updated:
2026-05-29
Start Date:
2016-01-26
Completion:
2032-07-01
Conditions
  • Epilepsy
  • Cancer
  • Brain Neoplasm
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page